{"text": ["Aduro", "(ADRO)", "Q4", "Earnings", "and", "Revenues", "Fall", "Shy", "of", "Estimates"], "created_at": "2019-02-28 23:13:40"}
{"text": ["Aduro", "(ADRO)", "Q4", "Earnings", "and", "Revenues", "Fall", "Shy", "of", "Estimates"], "created_at": "2019-02-28 23:13:40"}
{"text": ["Aduro", "(ADRO)", "Q4", "Earnings", "and", "Revenues", "Fall", "Shy", "of", "Estimates"], "created_at": "2019-02-28 21:13:09"}
{"text": ["Momenta", "Continues", "to", "Rebuild"], "created_at": "2019-02-28 20:10:10"}
{"text": ["Momenta", "Continues", "to", "Rebuild"], "created_at": "2019-02-28 20:10:10"}
{"text": ["Novartis", "faces", "shareholder", "criticism", "over", "drug", "prices", "at", "AGM"], "created_at": "2019-02-28 11:43:31"}
{"text": ["Novartis", "faces", "shareholder", "criticism", "over", "drug", "prices", "at", "AGM"], "created_at": "2019-02-28 10:51:26"}
{"text": ["Ionis", "Pharmaceuticals", "(IONS)", "Q4", "2018", "Earnings", "Conference", "Call", "Transcript"], "created_at": "2019-02-28 00:52:33"}
